SFG
ARLZ

SevenBridge Financial Group’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

SevenBridge Financial Group’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$2K – 685
2017
Q3 		$2K Hold
1,000
– – ﹤0.01% 585
2017
Q2 		$1K Hold
1,000
– – ﹤0.01% 643
2017
Q1 		$2K Buy
+1,000
New +$3.76K ﹤0.01% 598

Other funds holding ARLZ

PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BMCM
Bryn Mawr Capital Management Philadelphia, Pennsylvania $2.06B AUM 19.82% 1-Year Est. Return

SevenBridge Financial Group's ARLZ Position: Q4 2017 in Review

SevenBridge Financial Group sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q4 2017, closing a stake of 1,000 shares — an estimated $2K sold.

SevenBridge Financial Group first reported a position in ARLZ in Q1 2017 and held it in 3 quarters. The position peaked at $2K in Q3 2017. 63 funds tracked by Wall St. Rank hold ARLZ as of Q4 2017.

  • SevenBridge Financial Group reported no remaining Aralez Pharmaceuticals Inc. position as of Q4 2017 after selling out during the quarter.
  • SevenBridge Financial Group sold 1,000 Aralez Pharmaceuticals Inc. shares in Q4 2017, an estimated $2K.
  • SevenBridge Financial Group first reported a position in Aralez Pharmaceuticals Inc. in Q1 2017 and held it in 3 quarters.
  • SevenBridge Financial Group's Aralez Pharmaceuticals Inc. position peaked at $2K in Q3 2017.
  • 63 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q4 2017.

Based on SevenBridge Financial Group's 13F filing for Q4 2017, filed 20 Feb 2018.